D
Demant
The William Demant Group is a leading international hearing health care company which develops, manufactures
About Demant
Demant operates in the hearing healthcare industry, providing a wide range of products and services including hearing devices, hearing implants, diagnostic instruments, and professional hearing care. The company serves individuals with hearing loss, aiming to improve their quality of life through advanced hearing solutions. Demant's business model is centered around the development, manufacturing, and distribution of hearing healthcare products, generating revenue through the sale of these products and related services. The company leverages synergies across its diverse product portfolio to drive innovation and operational efficiency. Demant operates globally, with a strong presence in both developed and emerging markets. The company's profitability is driven by its core segments: Hearing Aids, Hearing Care, and Diagnostics. Recent financial performance has shown strong results, with an EBIT outlook upgrade driven by robust performance in these key areas. Demant is also committed to sustainability, continuously working to strengthen its operational practices to support sustainable healthcare globally.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1904
- Headquarters
- Smørumnedre, Denmark
- Listing
- IPO 2000
- Employees
- 4,844
- Open positions
- 134
- Dealroom signal
- 42.5/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Hearing
- Technology
- Deep Tech, Computer Vision, Connected Device
- Business model
- Manufacturing
- Investment activity
- 5 companies, latest Jun 2025
- Capital deployed
- $10M
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Mar 2023 | $55M | — | Nordic Investment Bank | ↗ |
| POST IPO DEBT✓Debt | Nov 2022 | $127M | — | European Investment Bank | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Demant is 49K monthly website visits, up 44.1% over the last three months. Demant's team grew 22.4% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
KIND HearingBurgwedel, Germany
$770Mvaluation
InvisioHvidovre, DenmarkAdvanced communication and hearing protection for defense professionals
$1Bvaluation
VirtualisPérols, France
→
Hellocare.aiClearwater, United StatesEnables technology professionals to connect and create an ecosystem around products and services
$188Mvaluation
Audika GroupeParis, FranceRetailer of hearing aids and hearing care solutions
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
European Investment Bank
Nordic Investment Bank
Other known investors1 additional known investor
Avesina
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Demant on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Demant’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.